Navigation Links
Gabriel Hortobagyi honored for mentoring minority researchers
Date:4/10/2013

se inhibitor to benefit women with post-menopausal hormone-receptive positive metastatic disease.

  • Established the role of bisphosphonates to treat patients with bone metastases and introduced paclitaxel and docetaxel in the management of metastatic and primary breast cancer.

    Hortobagyi also is a past-president of the American Society of Clinical Oncology. He is an elected member of 15 professional societies, honorary member of 17 others and received honorary doctorates from the universities of Modena (Italy), Nuevo Leon (Mexico) and Buenos Aires (Argentina). He is a member of the National Academy of Medicine and Sciences of Argentina, Hungary, and Mexico,

    He has earned many honors, including the Brinker International Award for Clinical Research, the medal of the Japanese Surgical Society and the Vermeille Medal from the city of Paris. French President Jacques Chirac named him Chevalier of the Order of la Legion d'Honneur de France. He also won the Horizon Achievement Award in Breast Cancer Research from Bristol-Myers Squibb Oncology and the Susan G. Komen Breast Cancer Foundation, the Glenn Robbins Award, and was named a World Leader in Oncology by the Mexican Society of Oncology. He received the Cruz Civica from the Colombian Government; was elected to receive the ASCO Statesman Award, the Charles A. LeMaistre Outstanding Achievement Award and the John Mendelsohn Lifetime Scientific Achievement Award; also the Dr. Jenaro Haddock Prize and Memorial lecture and the Bob Pinedo Cancer Care Award from the Society for Translational Oncology, the Jill Rose Award from the Breast Cancer Research Foundation and the William L. McGuire Award at the CTRC-AACR San Antonio Breast Cancer Symposium.

    Hortobagyi has contributed more than 800 articles to scientific journals. He was co-founder of the World Summit Against Cancer, an international group of scientists, health care professionals, patient advocates, economists, lawmakers and
    '/>"/>


  • Contact: Scott Merville
    smerville@mdanderson.org
    713-516-4855
    University of Texas M. D. Anderson Cancer Center
    Source:Eurekalert

    Page: 1 2 3 4

    Related medicine news :

    1. Gabrielles Angel Foundation for Cancer Research announces 2 collaborative research grants
    2. Kroenke honored for outstanding contributions in clinical research training
    3. Callahan honored for improving older adults health in their doctors offices
    4. US Army internal medicine Masters, Fellows honored by American College of Physicians
    5. Internationally known expert in ovarian cancer to be honored at the ASCO Annual Meeting
    6. Mayo Clinic Alzheimers researcher honored twice in a month
    7. USHEALTH Advisors L.L.C. Honored as Bronze Stevie® Award Winner in 2012 American Business Awards
    8. Eight scientists honored in first annual Golden Goose Awards
    9. 2 Scripps Research Institute scientists honored by American Chemical Society
    10. Dr. Jonathan Lass to be honored by Eye Bank Association of America
    11. Collegiate inventors honored for innovative science and technology advances
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/28/2015)... 28, 2015 For those people who ... the Mesothelioma Applied Research Foundation (Meso Foundation) ... March 3, starting at 9:30 AM. , The live ... The broadcast can be accessed through any browser on ... , The Symposium is a unique event that covers ...
    (Date:2/28/2015)... Louis, MO (PRWEB) February 28, 2015 ... leading provider of outsourced sales, marketing and supply ... their client, BIOTA Botanicals, is bringing its award ... Celebrated worldwide, BIOTA Botanicals’ products are specifically created ... herbal care experts, BIOTA is committed to marrying ...
    (Date:2/28/2015)... York, NY (PRWEB) February 28, 2015 ... discuss federal testosterone lawsuits that have been filed by ... for the second week in March, the Firm notes. ... Court’s website, parties involved in the federal litigation will ... address matters related to prescription therapy treatments designed to ...
    (Date:2/28/2015)... 28, 2015 On Thursday, February 26th, Forbes ... Easy For Scammers To Steal Your Data , which stresses ... hands on a DIY phishing kit, or any kind of ... on another important point about how everyone’s cyber security is ... implemented, “like compromising legitimate content management systems or blogs in ...
    (Date:2/28/2015)... Developers of FCPX plugins and theme templates ... Final Cut Pro X entitled FCPX Overlay Chromatic Grunge 6K ... total control over 6k lens dirt overlays inside Final Cut ... “FCPX Overlay Chromatic was professionally designed to add level of ... Overlay Chromatic Grunge 6K is a resourceful tool from Pixel ...
    Breaking Medicine News(10 mins):Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4Health News:Pixel Film Studios released a new overlay plugin entitled FCPX Overlay Chromatic Grunge 6K exclusively for Final Cut Pro X users 2
    ... Inc. announced today an initiation of Phase I clinical ... of Alzheimer,s disease. The results of Phase I studies ... on these and other results, Avineuro Pharmaceuticals, Inc. plans ... Q2 2009. Avineuro Pharmaceuticals, Inc. presented at the 9th ...
    ... Show U.S. Rx Abandonment Rate Up 34 Percent Since ... 2008BRIDGEWATER, N.J., April 7 /PRNewswire/ ... of information and business intelligence for students, professionals and ... pharmaceutical industry, today released its annual analysis of the ...
    ... services , ... Dallas, TX (Vocus) April 7, 2009 ... Blue Island, Illinois has selected Broadlane as the exclusive provider of ... approximate $25 million in annual spend., , , , ,MetroSouth Medical ...
    ... to compliment the Small Business Administration,s recent announcement of $730 million ... banks and make it easier for entrepreneurs and start-ups to get ... ... (PRWEB) April 7, 2009 -- Health Career Agents announces SBA Pre-Approval ...
    ... vital for charities - Charity websites help raise ... networks - Women in Need helps women from ... illness, rape & abuseHARTFORD, England, April 7 ... from Hartford, Cheshire, has recently completed a newly ...
    ... Intervet/Schering-Plough Animal Health today announces that the ... testing goes to Dr. Ivo Claassen for a ... Veterinary Institute (CVI), Lelystad (the Netherlands). The announcement ... an independent expert jury panel and Professor of ...
    Cached Medicine News:Health News:2008 Sees Significant Rise in Prescription Abandonment and Uptake of Generics 2Health News:2008 Sees Significant Rise in Prescription Abandonment and Uptake of Generics 3Health News:2008 Sees Significant Rise in Prescription Abandonment and Uptake of Generics 4Health News:MetroSouth Medical Center Selects Broadlane to Provide Comprehensive Supply Chain Services 2Health News:MetroSouth Medical Center Selects Broadlane to Provide Comprehensive Supply Chain Services 3Health News:MetroSouth Medical Center Selects Broadlane to Provide Comprehensive Supply Chain Services 4Health News:Health Career Agents Announces SBA Pre-Approval Program to Launch a Healthcare Recruiting Business 2Health News:Health Career Agents Announces SBA Pre-Approval Program to Launch a Healthcare Recruiting Business 3Health News:Local Web Design Agency Launches Leprosy Charity Website for Women in Need 2Health News:Dieter Luetticken Award 2008 Recognizes Development of New Vaccine Quality Control Assay 2Health News:Dieter Luetticken Award 2008 Recognizes Development of New Vaccine Quality Control Assay 3
    (Date:2/27/2015)... Feb. 27, 2015 Pharmaceutical and biotech marketers ... products for the same indication. This can be a ... to prevent one of their brands from gaining market ... to recent research by benchmarking firm, Best Practices, LLC, ... brands rather than together as part of a franchise. ...
    (Date:2/27/2015)... 2015  Pharmacyclics, Inc. (NASDAQ: PCYC ... published in the Proceedings of the National ... showed when ibrutinib (IMBRUVICA ® ) was combined ... of tumor growth was enhanced suggesting a greater ... cancers and solid tumors with the combination. IMBRUVICA ...
    (Date:2/27/2015)... Feb. 27, 2015 Securities lawyers at ... Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP ) in ... Concerned SLXP investors are encouraged to contact attorney Hamilton ... The investigation focuses upon the shareholder value of the ... would receive only $158.00 per share in cash. At ...
    Breaking Medicine Technology:New Report Details How to Expand a Pharmaceutical Product Portfolio without Cannibalizing an Established Brand 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 4In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 5In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 6In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 7In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 8In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 9
    ... BIRMINGHAM, Ala. , Feb. 4 BioCryst Pharmaceuticals, ... the fourth quarter and year ended December 31, 2009 ... strides towards the goal of building an enduring and successful ... Chief Executive Officer of BioCryst Pharmaceuticals.  "Peramivir has delivered the ...
    ... REDWOOD CITY, Calif. , Feb. 3 Genomic Health, ... ended December 31, 2009 , which included 35 percent revenue growth ... revenue for the fourth quarter of 2009 increased to $39.6 million ... 2008.  Product revenue from the Onco type DX® breast cancer test ...
    Cached Medicine Technology:BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 2BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 3BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 4BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 5BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 6BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 7BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 8BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 9BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 10Genomic Health Announces Year-End 2009 Financial Results 2Genomic Health Announces Year-End 2009 Financial Results 3Genomic Health Announces Year-End 2009 Financial Results 4Genomic Health Announces Year-End 2009 Financial Results 5Genomic Health Announces Year-End 2009 Financial Results 6Genomic Health Announces Year-End 2009 Financial Results 7Genomic Health Announces Year-End 2009 Financial Results 8Genomic Health Announces Year-End 2009 Financial Results 9Genomic Health Announces Year-End 2009 Financial Results 10Genomic Health Announces Year-End 2009 Financial Results 11Genomic Health Announces Year-End 2009 Financial Results 12
    ... SBI RingFix is a modular external fixation ... large variety of clinical needs. Originally marketed ... has a successful 20 year history of ... Developed around the principles of the Ilizarov ...
    ... QuickLink™ Delivery System is ... designed to assemble brachytherapy ... Connectors into seed trains ... with variable seed to ...
    ... ImmunoCard STAT! EHEC is the first one-step 20 ... Toxin 1 and 2 produced by Enterohemorrhagic Escherichia ... McConkey broth overnight enrichment of fecal specimens and ... 100% specificity., The separate result for Toxin 1 ...
    Classic, stylish, and preppy, this collection features men's, women's and unisex styles....
    Medicine Products: